HealthLeaders Media September 3, 2024
Advocates are once again lobbying the White House and Congress to extend a waiver on using telemedicine to prescribe controlled medications, while the DEA prepares a new rule that could cause even more discord.
KEY TAKEAWAYS
– A pandemic-era waiver that enables providers to use telemedicine to prescribe controlled medications is set to expire at the end of the year.
– The DEA is awaiting federal review of new rules for telemedicine prescriptions, though some say the proposal will further restrict the use of virtual care.
– Telehealth advocates are asking for the waiver to be extended another two years so that the DEA has time to create rules that would appeal to everyone.
Telehealth advocates are gearing up for...
Today's Sponsors
Today's Sponsor